期刊文献+

氨基胍对腹膜间皮细胞醛糖还原酶活性的影响

Effect of Aminoguanidine on Activity of Aldose Reductase in Peritoneal Mesothelial Cells
暂未订购
导出
摘要 目的观察氨基胍对腹膜间皮细胞醛糖还原酶活性的影响,探讨氨基胍对腹膜间皮细胞醛糖还原酶的调节作用。方法采用人的网膜作为细胞来源,胰蛋白酶-EDTA消化法进行人腹膜间皮细胞的分离、培养,间接免疫荧光法对第二代细胞进行鉴定;用生长期细胞进行实验,培养6d后测AR活性;应用紫外分光光度计记录NADPH在340nm处的吸光值测定醛糖还原酶活性。结果实验组氨基胍组醛糖还原酶的活性与对照组比较仅略下降,无显著性差异。结论氨基胍并不能明显地抑制腹膜间皮细胞醛糖还原酶的活性。 Objective To observe the effect of aminoguanidine on activity of aldose reductase in peritoneal mesothelial cells and explore its regulation. Methods Mesothelial cells were isolated from the omental tissue of consenting patients by typsin-EDTA disaggregation and indirect immunofluorescence was used for identification. Confluent HPMCs were maintained in M199 medium supplemented with 10%FBS, 1.5% GS and 10mmol/L aminoguanidine for 6 days. Aldose reductase activity was measured on spectrophotometer by monitoring the absorbance of NADPH at 340nm. Results When HPMC was incubated with glucose in the presence of aminoguanidine(10mmol/L) for 6 days, there was a decrease in aldose reductase activity,but the difference compared to control was not significant. Conclusion Aminoguanidine can not significantly inhibit aldose reductase activity of peritoneal mesothelial cells.
出处 《中国现代医生》 2008年第7期49-50,共2页 China Modern Doctor
关键词 氨基胍 腹膜间皮细胞 醛糖还原酶 多元醇通路 Aminoguanidine Peritoneal mesothelial cells Aldose reductase Polyol pathway
  • 相关文献

参考文献15

  • 1[1]Masato T,Masayuld O,Yoshiyuki H,et al.Aldose reductase mRNA expression and its activity are induced by glucose in fetal rat aortic smooth muscle(A10)cells[J].Life Science,1992,51(10):719-726.
  • 2[2]Nishimura C,Yamaoka T,Mizuumi M,et al.Purification and eharacterization of the recombinant human aldose reductase ex pressed in baculovirus system[J].Biochim Biophys Acta,1991,1078(2):171-178.
  • 3[3]Williamann JR,Chnag K,Franges M,et al.Hyperglycemic pseudohypoxia and diabetic complications[J].Diabetes,1993,42(7):801-13.
  • 4[4]Harriti Y.Diebetes and the nervus system[J].Endocrinol Metab Clin N Amer.1996.25(2):293-318.
  • 5[5]Costanfino L,Rastelli G,Vianello P,et al.Diabetes complications and their potential prevention:aldose reductase inhibition and other approachs[J].Med Res Rev,1999,19(1):3-24.
  • 6[6]Tilton RG,Chang K,Hasan KS,et al.Prevention of diabetic vascular dysfunction by guanidines:inhibition of nitric oxide synthase versuw advanced glycation end-predueti formation[J].Diabetes,1993,42(2):221-232.
  • 7[7]Hammes HP,Martin S,Federlink,et al.Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy[J].Proc Nail Acad Sci USA.1991.88(24):11555-11558.
  • 8[8]Soulis-Liparota T,Cooper M,Papazoglou D,et al.Retardation by aminoguanidine of development of albuminuria,mesangial expansion,and tissue fluorescence in streptozoein-induce diabetic rat[J].Diabetes,1991,40(10):1328-1334.
  • 9[9]Kumair K,Umar S,Bansal V,et al.Inhibition of Diabetes-asseciated complications by nucleophilie componnds[J].Diabetes,1991,40(8):1079-1084.
  • 10[10]Kumair K,Umar S,Bansal V,et al.Monoaminoguanidine inhibits aldose reduetase[J].Biochem Phannacol,1991,41(10):1527-1528.

二级参考文献24

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部